Clinical Trial

Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to compare two treatment approaches for diabetic foot ulcers (DFUs): the standard of care (SOC) alone versus SOC combined with OCM. Researchers will evaluate whether adding OCM increases the likelihood of ulcers healing completely by the end of the trial period.
Protocol Amendment History 1 change
notable Enrollment increased: 130 -> 180 participants 2026-08-05
Trial Details
NCT Number NCT07161830
Lead Sponsor Omeza, LLC
Collaborators: SygNola, LLC
Conditions Diabetic Foot Ulcer
Enrollment 180 participants
Start Date 2025-12-04
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-04